Press Releases & Media
Press Releases
Patient Enrollment (2016)
Study Results (March 2020)
- University of Alberta Press Release
- American College of Cardiology Press Release
- Bayer Press Release
- Merck Press Release
U.S. FDA Approval (January 2021)
Media Coverage
- Interview with Drs. Peter Block and Paul Armstrong (ACC.org)
- VICTORIA: Vericiguat reduces events in high-risk HF (Helio -Cardiology Today)
- Vericiguat Cuts Admissions in HFrEF (MedPage Today)
- VICTORIA: Vericiguat seen as novel success in tough-to-treat, high-risk heart failure (Medscape)
- New drug could potentially offer better treatment for chronic heart failure (Folio)
- VICTORIA: With Vericiguat, Less CV Death, Heart Failure Hospitalization Among High-Risk Patients (AJMC)
- House Call: VICTORIA, ACC 2020 Recap (MD Magazine)
- Interview with Drs. Harriette Van Spall and Paul Armstrong (Radcliffe Cardiology)
- Be The Cure Research Story: Deborah McLeod’s Experience as a Participant in the VICTORIA trial (BeTheCure)
- MedEd Talks: Heart Failure Management: Guideline-directed Therapy and Unmet Needs With Drs. Paul Armstrong and Carolyn Lam (Healio)
- MedEd Talks: sGC Modulators: Unique Mechanism of Action and Rationale for Use in Heart Failure With Drs. Paul Armstrong and Carolyn Lam (Healio)
- MedEd Talks: The Clinical Evidence: Efficacy and Safety of sGC Modulators in Heart Failure With Reduced Ejection Fraction With Drs. Paul Armstrong and Javed Butler (Healio)
- MedEd Talks: sGC Modulators: Role in Current Treatment Paradigms for Heart Failure With Drs. Paul Armstrong and Javed Butler (Healio)
- FDA approves new cardiovascular drug based on study from U of A’s Canadian VIGOUR Centre (Folio)
- In high-risk patients with HF, CAD confers worse outcomes (Healio)
- Coronary Artery Disease and Cardiovascular Outcomes in Heart Failure: Insights from the Vericiguat Global Study in Patients with Heart Failure and Reduced Ejection Fraction (VICTORIA) (Cardiology Talk)
